We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Relx Plc | LSE:REL | London | Ordinary Share | GB00B2B0DG97 | ORD 14 51/116P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
110.00 | 3.04% | 3,723.00 | 3,727.00 | 3,728.00 | 3,730.00 | 3,631.00 | 3,643.00 | 2,421,014 | 16:35:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Miscellaneous Publishing | 9.16B | 1.78B | 0.9554 | 39.02 | 67.35B |
Date | Subject | Author | Discuss |
---|---|---|---|
07/7/2021 09:45 | Yes starting to move at last, hopefully their Exhibitions business will see some European show's starting up | smcni1968 | |
07/7/2021 09:22 | Anyone following this. Chart looks great from a technical point of view | beergut | |
11/2/2021 10:54 | Very respectable figures in the current climate. | spoole5 | |
23/12/2020 10:33 | You can give a thumbs up by clicking through on Read Full Thread - the extra buttons appear then. Quiet boards are a good sign in my opinion... nothing to talk about because the company is simply getting on doing what it does well without fuss. | 1aconic | |
17/12/2020 11:30 | I've seen your post SMCNI1968, however since I'm no longer a paying subscriber to ADVFN I don't think I can use the thumbs up feature. Quiet boards on ADVFN normally are a positive since shares are not high profile and bought up through speculators and some amateurs. With regard to RELX, I think it is too big a market cap to generally be affected by bulletin board messages anyway. Overall I think this is a quality business, beaten down by the affects of Covid-19 with the market over pricing down the affect of covid on exhibitions (considering it's relative % contribution to group results). I think once we are in 2021 and exhibitions are in person up and running again I anticipate a re-rating of this share. Over the last few months and for the next few months I continue to build my holding in RELX. | wildshot | |
16/12/2020 22:02 | Very quiet board- if you see this post could you give it a thumbs up or down just to see if anyone even looks? | smcni1968 | |
08/10/2020 01:05 | Why is this sinking when Informa which is much more reliant on exhibitions is fairly stable? | smcni1968 | |
25/8/2020 11:04 | Nice story here | netcurtains | |
23/7/2020 20:50 | Thanks pvb. Results not that bad under the circumstances, obviously the exhibitions business was gonna be awful, not quite sure why that seemed to be a shock. | spoole5 | |
23/7/2020 15:58 | 2020 Interim Results Results badly effected by COVID-19, via "Exhibitions" business, but Interim dividend maintained at 13.6p | pvb | |
23/7/2020 15:52 | I have created this new RELX (LSE:REL) thread because every time I try to look at any of the existing threads on this company it is just a confusing mess! | pvb | |
23/7/2020 15:51 | RELX - Was Reed Elsevier | pvb | |
24/3/2020 13:27 | Still buying back shares, can't be too concerned! | spoole5 | |
13/2/2020 10:43 | Backed up by a decent set of results. | patientcapital | |
24/1/2020 14:35 | New ATH I think. | patientcapital | |
21/2/2019 19:40 | Thanks both. I guess I am biased also because I dont like gearing of 200% or buybacks financed by debt, even though appears to be a Company with long history of expansion as you say. Agree your sentiments, long may it remain British controlled and independent. | electronic303 | |
21/2/2019 18:09 | There is a reason it is highly rated, it delivers steady growth year in year out. Will continue to hold | spoole5 | |
21/2/2019 17:33 | I'm afraid I take the market's present view but having held since 1990 I suppose I am slightly biased. At various times it has often looked too highly rated only to continue to impress. I bought a number of different holdings at that particular moment and Reed International is one of the very few that have remained independent. Long may it remain so. | patientcapital |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions